These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12006218)

  • 1. Relation of Apo E and ACE genes to cognitive performance in chronic alcoholic patients.
    Bartrés-Faz D; Clemente IC; Monràs M; Muñoz M; López-Alomar A; Valveny N; Moral P; Gual A; Sánchez-Turet M; Guardia J; Junqué C
    Addict Biol; 2002 Apr; 7(2):227-33. PubMed ID: 12006218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
    Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
    Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E4 genotype is not associated with short-term cognition deficits during alcohol withdrawal.
    Wilhelm J; von Ahsen N; Frieling H; Hillemacher T; Bayerlein K; Bönsch D; Ziegenbein M; Kornhuber J; Bleich S
    Alcohol; 2005 Nov; 37(3):151-6. PubMed ID: 16713503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
    Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
    J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
    Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.
    O'Hara R; Sommer B; Way N; Kraemer HC; Taylor J; Murphy G
    J Psychiatr Res; 2008 Feb; 42(3):199-204. PubMed ID: 17250852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
    Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is epsilon4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension?
    Yilmaz H; Isbir T; Ağaçhan B; Aydin M
    Cell Biochem Funct; 2001 Sep; 19(3):191-5. PubMed ID: 11494308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
    Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
    Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease.
    Finton MJ; Lucas JA; Rippeth JD; Bohac DL; Smith GE; Ivnik RJ; Petersen RC; Graff-Radford NR
    J Int Neuropsychol Soc; 2003 Jul; 9(5):751-9. PubMed ID: 12901781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
    Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
    Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphisms of APO-E in Colombian women with osteoporosis: correlation with clinical and social risk variables].
    Villarreal E; Bermúdez A
    Biomedica; 2004 Mar; 24(1):50-5. PubMed ID: 15239601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation of apolipoprotein E polymorphism to clinically diagnosed fatty liver disease].
    Lee DM; Lee SO; Mun BS; Ahn HS; Park HY; Lee HS; Kim DG
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):355-62. PubMed ID: 12506239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.